<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">35624969</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-3425</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2022</Year><Month>Apr</Month><Day>29</Day></PubDate></JournalIssue><Title>Brain sciences</Title><ISOAbbreviation>Brain Sci</ISOAbbreviation></Journal><ArticleTitle>The Clinical Spectrum of Autoimmune-Mediated Neurological Diseases in Paediatric Population.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">584</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/brainsci12050584</ELocationID><Abstract><AbstractText>Neurological autoimmune diseases have various origins and pathogeneses. Specific antibodies are associated with paraneoplastic syndromes, other infectious agents, or inherited disorders. We aim to evaluate the relation between the autoantibodies, the chosen symptoms, demographic characteristics, and infection history. We retrospectively analysed 508 children during neurological diagnostics. We investigated serum antineuronal, IgG, IgM anti-ganglioside, and anti-aquaporin-4 in both the serum and cerebrospinal fluid (CSF) anti-cell surface and anti-synaptic protein antibodies in 463, 99, 44, 343, and 119 patients, respectively. The CSF polymerase chain reaction detection of Herpesviridae, enterovirus, B19 parvovirus, adenovirus, and parechovirus involved 261 patients. We included available clinical information and electroencephalographic, radiologic, and microbiological results. The IgM anti-ganglioside antibodies increased the risk of tics and positive symptoms (<i>p</i> = 0.0345, <i>p</i> = 0.0263, respectively), the anti-glutamic acid decarboxylase particle of paresis (<i>p</i> = 0.0074), and anti-neuroendothelium of mutism (<i>p</i> = 0.0361). Anti-neuroendothelium, IgM anti-ganglioside, and CSF anti-N-methyl-D-aspartate antibodies were more often associated with consciousness loss (<i>p</i> = 0.0496, <i>p</i> = 0.0044, <i>p</i> = 0.0463, respectively). Anti-myelin antibodies co-occured with Herpes simplex virus (HSV)-2 IgG (<i>p</i> = 0.0415), anti-CV2 with HSV-1 IgM (<i>p</i> = 0.0394), whereas anti-glial fibrillary acidic protein was linked with past Epstein-Barr virus infection. The anti-ganglioside IgM and anti-myelin particles were bilaterally correlated (<i>p</i> = 0.0472). The clinical pictures may overlap, requiring specialistic diagnostics. We noticed the links between the infection aetiology and the specific autoantibody's positivity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lubarski</LastName><ForeName>Karol</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2354-4484</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences, 27/33 Szpitalna St., 60-572 Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mania</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0141-2560</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences, 27/33 Szpitalna St., 60-572 Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Michalak</LastName><ForeName>Sławomir</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Division of Neurochemistry and Neuropathology, Poznan University of Medical Sciences, 49 Przybyszewskiego St., 60-355 Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osztynowicz</LastName><ForeName>Krystyna</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Division of Neurochemistry and Neuropathology, Poznan University of Medical Sciences, 49 Przybyszewskiego St., 60-355 Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazur-Melewska</LastName><ForeName>Katarzyna</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-2695-4649</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences, 27/33 Szpitalna St., 60-572 Poznan, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figlerowicz</LastName><ForeName>Magdalena</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-4731-0658</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and Child Neurology, Poznan University of Medical Sciences, 27/33 Szpitalna St., 60-572 Poznan, Poland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>04</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Brain Sci</MedlineTA><NlmUniqueID>101598646</NlmUniqueID><ISSNLinking>2076-3425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">child neurology</Keyword><Keyword MajorTopicYN="N">encephalitis</Keyword><Keyword MajorTopicYN="N">involuntary movement</Keyword><Keyword MajorTopicYN="N">neuroepidemiology</Keyword><Keyword MajorTopicYN="N">neuroimmunology</Keyword><Keyword MajorTopicYN="N">neuroinflammation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>4</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>29</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>4</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35624969</ArticleId><ArticleId IdType="pmc">PMC9138824</ArticleId><ArticleId IdType="doi">10.3390/brainsci12050584</ArticleId><ArticleId IdType="pii">brainsci12050584</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>D’Alonzo R., Mencaroni E., Di Genova L., Laino D., Principi N., Esposito S. Pathogenesis and Treatment of Neurologic Diseases Associated With Mycoplasma Pneumoniae Infection. Front. Microbiol. 2018;9:2751. doi: 10.3389/fmicb.2018.02751.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.02751</ArticleId><ArticleId IdType="pmc">PMC6255859</ArticleId><ArticleId IdType="pubmed">30515139</ArticleId></ArticleIdList></Reference><Reference><Citation>Figlerowicz M., Mazur-Melewska K., Kemnitz P., Mania A. Pediatric Postviral Autoimmune Disorders of the CNS. Future Virol. 2020;15:307–315. doi: 10.2217/fvl-2019-0162.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl-2019-0162</ArticleId></ArticleIdList></Reference><Reference><Citation>Popławska-Domaszewicz K., Florczak-Wyspiańska J., Kozubski W., Michalak S. Paraneoplastic Movement Disorders. Rev. Neurosci. 2018;29:745–755. doi: 10.1515/revneuro-2017-0081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2017-0081</ArticleId><ArticleId IdType="pubmed">29561731</ArticleId></ArticleIdList></Reference><Reference><Citation>Graus F. Recommended Diagnostic Criteria for Paraneoplastic Neurological Syndromes. J. Neurol. Neurosurg. Psychiatry. 2004;75:1135–1140. doi: 10.1136/jnnp.2003.034447.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2003.034447</ArticleId><ArticleId IdType="pmc">PMC1739186</ArticleId><ArticleId IdType="pubmed">15258215</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbagallo M., Vitaliti G., Pavone P., Romano C., Lubrano R., Falsaperla R. Pediatric Autoimmune Encephalitis. J. Pediatr. Neurosci. 2017;12:130. doi: 10.4103/jpn.JPN_185_16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jpn.JPN_185_16</ArticleId><ArticleId IdType="pmc">PMC5588635</ArticleId><ArticleId IdType="pubmed">28904568</ArticleId></ArticleIdList></Reference><Reference><Citation>Boukhvalova M.S., Mortensen E., Mbaye A., Lopez D., Kastrukoff L., Blanco J.C.G. Herpes Simplex Virus 1 Induces Brain Inflammation and Multifocal Demyelination in the Cotton Rat Sigmodon Hispidus. J. Virol. 2019;94:e01161-19. doi: 10.1128/JVI.01161-19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01161-19</ArticleId><ArticleId IdType="pmc">PMC6912097</ArticleId><ArticleId IdType="pubmed">31597775</ArticleId></ArticleIdList></Reference><Reference><Citation>Koga M., Takahashi T., Kawai M., Fujihara K., Kanda T. A Serological Analysis of Viral and Bacterial Infections Associated with Neuromyelitis Optica. J. Neurol. Sci. 2011;300:19–22. doi: 10.1016/j.jns.2010.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.10.013</ArticleId><ArticleId IdType="pubmed">21056429</ArticleId></ArticleIdList></Reference><Reference><Citation>Meroni P., Khamashta M., Youinou P., Shoenfeld Y. Mosaic of Anti-Endothelial Antibodies: Review of the First International Workshop on Anti-Endothelial Antibodies: Clinical and Pathological Significance Milan, 9 November 1994. Lupus. 1995;4:95–99. doi: 10.1177/096120339500400203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339500400203</ArticleId><ArticleId IdType="pubmed">7795630</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y., Tsukada N., Koh C.-S., Yanagisawa N. Anti-Endothelial Cell Antibodies and Circulating Immune Complexes in the Sera of Patients with Multiple Sclerosis. J. Neuroimmunol. 1987;17:49–59. doi: 10.1016/0165-5728(87)90030-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-5728(87)90030-0</ArticleId><ArticleId IdType="pubmed">2445776</ArticleId></ArticleIdList></Reference><Reference><Citation>Koszewicz M., Michalak S., Bilinska M., Budrewicz S., Zaborowski M., Slotwinski K., Podemski R., Ejma M. Is Peripheral Paraneoplastic Neurological Syndrome Possible in Primary Brain Tumors? Brain Behav. 2016;6:e00465. doi: 10.1002/brb3.465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.465</ArticleId><ArticleId IdType="pmc">PMC4851647</ArticleId><ArticleId IdType="pubmed">27186442</ArticleId></ArticleIdList></Reference><Reference><Citation>Meroni P.L., Tincani A., Sepp N., Raschi E., Testoni C., Corsini E., Cavazzana I., Pellegrini S., Salmaggi A. Endothelium and the Brain in CNS Lupus. Lupus. 2003;12:919–928. doi: 10.1191/0961203303lu503oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/0961203303lu503oa</ArticleId><ArticleId IdType="pubmed">14714912</ArticleId></ArticleIdList></Reference><Reference><Citation>Margari F., Petruzzelli M.G., Mianulli R., Toto M., Pastore A., Bizzaro N., Tampoia M. Anti-Brain Autoantibodies in the Serum of Schizophrenic Patients: A Case-Control Study. Psychiatry Res. 2013;210:800–805. doi: 10.1016/j.psychres.2013.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2013.09.006</ArticleId><ArticleId IdType="pubmed">24103908</ArticleId></ArticleIdList></Reference><Reference><Citation>Annunziata P., Cioni C., Moschini F., Riccucci A., Guazzi G.C. Serum Anti-Brain Endothelium Antibodies and Cognitive Assessment in Patients with Binswanger’s Encephalopathy. J. Neurol. Sci. 1995;128:96–102. doi: 10.1016/0022-510X(94)00215-A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)00215-A</ArticleId><ArticleId IdType="pubmed">7722540</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalak S., Gruszczyńska A., Popławska K., Żurawicz P., Kozubski W. Clinical significance of anti-MAG, anti-myelin and anti-neuroendothelium antibodies. Neuroskop. 2011;13:100–105.</Citation></Reference><Reference><Citation>Kanda T., Iwasaki T., Yamawaki M., Tai T., Mizusawa H. Anti-GM1 Antibody Facilitates Leakage in an in Vitro Blood-Nerve Barrier Model. Neurology. 2000;55:585–587. doi: 10.1212/WNL.55.4.585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.55.4.585</ArticleId><ArticleId IdType="pubmed">10953200</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Xu Y., Ren H., Zhu Y., Peng B., Cui L. Autoimmune GFAP Astrocytopathy after Viral Encephalitis: A Case Report. Mult. Scler. Relat. Dis. 2018;21:84–87. doi: 10.1016/j.msard.2018.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2018.02.020</ArticleId><ArticleId IdType="pubmed">29499442</ArticleId></ArticleIdList></Reference><Reference><Citation>Troxell R.M., Christy A. Atypical Pediatric Demyelinating Diseases of the Central Nervous System. Curr. Neurol. Neurosci. Rep. 2019;19:95. doi: 10.1007/s11910-019-1015-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11910-019-1015-y</ArticleId><ArticleId IdType="pubmed">31773416</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang B., McKeon A., Hinson S.R., Kryzer T.J., Pittock S.J., Aksamit A.J., Lennon V.A. Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis. JAMA Neurol. 2016;73:1297. doi: 10.1001/jamaneurol.2016.2549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.2549</ArticleId><ArticleId IdType="pubmed">27618707</ArticleId></ArticleIdList></Reference><Reference><Citation>Oger V., Bost C., Salah L., Yazbeck E., Maurey H., Bellesme C., Sevin C., Adamsbaum C., Chrétien P., Benaiteau M., et al. Mild Encephalitis/Encephalopathy with Reversible Splenial Lesion Syndrome: An Unusual Presentation of Anti-GFAP Astrocytopathy. Eur. J. Paediatr. Neurol. 2020;26:89–91. doi: 10.1016/j.ejpn.2020.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2020.03.002</ArticleId><ArticleId IdType="pubmed">32340854</ArticleId></ArticleIdList></Reference><Reference><Citation>Salama S., Khan M., Pardo S., Izbudak I., Levy M. MOG Antibody–Associated Encephalomyelitis/Encephalitis. Mult. Scler. 2019;25:1427–1433. doi: 10.1177/1352458519837705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458519837705</ArticleId><ArticleId IdType="pmc">PMC6751007</ArticleId><ArticleId IdType="pubmed">30907249</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoles E., Hauben E., Palgi O., Agranov E., Gothilf A., Cohen A., Kuchroo V., Cohen I.R., Weiner H., Schwartz M. Protective Autoimmunity Is a Physiological Response to CNS Trauma. J. Neurosci. 2001;21:3740–3748. doi: 10.1523/JNEUROSCI.21-11-03740.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-11-03740.2001</ArticleId><ArticleId IdType="pmc">PMC6762728</ArticleId><ArticleId IdType="pubmed">11356861</ArticleId></ArticleIdList></Reference><Reference><Citation>Berger T., Rubner P., Schautzer F., Egg R., Ulmer H., Mayringer I., Dilitz E., Deisenhammer F., Reindl M. Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event. N. Engl. J. Med. 2003;349:139–145. doi: 10.1056/NEJMoa022328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa022328</ArticleId><ArticleId IdType="pubmed">12853586</ArticleId></ArticleIdList></Reference><Reference><Citation>Reindl M., Waters P. Myelin Oligodendrocyte Glycoprotein Antibodies in Neurological Disease. Nat. Rev. Neurol. 2019;15:89–102. doi: 10.1038/s41582-018-0112-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0112-x</ArticleId><ArticleId IdType="pubmed">30559466</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters P., Fadda G., Woodhall M., O’Mahony J., Brown R.A., Castro D.A., Longoni G., Irani S.R., Sun B., Yeh E.A., et al. Serial Anti–Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes. JAMA Neurol. 2020;77:82. doi: 10.1001/jamaneurol.2019.2940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2940</ArticleId><ArticleId IdType="pmc">PMC6763982</ArticleId><ArticleId IdType="pubmed">31545352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosius W., Michalak S., Kozubski W., Kalinowska A. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management. Int. J. Mol. Sci. 2020;22:100. doi: 10.3390/ijms22010100.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010100</ArticleId><ArticleId IdType="pmc">PMC7795410</ArticleId><ArticleId IdType="pubmed">33374173</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato D.K., Callegaro D., Lana-Peixoto M.A., Waters P.J., de Haidar Jorge F.M., Takahashi T., Nakashima I., Apostolos-Pereira S.L., Talim N., Simm R.F., et al. Distinction between MOG Antibody-Positive and AQP4 Antibody-Positive NMO Spectrum Disorders. Neurology. 2014;82:474–481. doi: 10.1212/WNL.0000000000000101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000101</ArticleId><ArticleId IdType="pmc">PMC3937859</ArticleId><ArticleId IdType="pubmed">24415568</ArticleId></ArticleIdList></Reference><Reference><Citation>López-Chiriboga A.S., Majed M., Fryer J., Dubey D., McKeon A., Flanagan E.P., Jitprapaikulsan J., Kothapalli N., Tillema J.-M., Chen J., et al. Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG–Associated Disorders. JAMA Neurol. 2018;75:1355. doi: 10.1001/jamaneurol.2018.1814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.1814</ArticleId><ArticleId IdType="pmc">PMC6248120</ArticleId><ArticleId IdType="pubmed">30014148</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick D. Herpes-Simplex Virus as Cause of Bell’s Palsy. Lancet. 1972;299:937–939. doi: 10.1016/S0140-6736(72)91499-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(72)91499-7</ArticleId><ArticleId IdType="pubmed">4112101</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato R., Okanari K., Maeda T., Kaneko K., Takahashi T., Kenji I. Postinfectious Acute Disseminated Encephalomyelitis Associated With Antimyelin Oligodendrocyte Glycoprotein Antibody. Child Neurol. Open. 2020;7:2329048X2094244. doi: 10.1177/2329048X20942442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2329048X20942442</ArticleId><ArticleId IdType="pmc">PMC7361478</ArticleId><ArticleId IdType="pubmed">32704520</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura Y., Nakajima H., Tani H., Hosokawa T., Ishida S., Kimura F., Kaneko K., Takahashi T., Nakashima I. Anti-MOG Antibody-Positive ADEM Following Infectious Mononucleosis Due to a Primary EBV Infection: A Case Report. BMC Neurol. 2017;17:76. doi: 10.1186/s12883-017-0858-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-017-0858-6</ArticleId><ArticleId IdType="pmc">PMC5395865</ArticleId><ArticleId IdType="pubmed">28420330</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M.-M., Zhang X.-H. Cross-Reactivity between Human Cytomegalovirus Peptide 981-1003 and Myelin Oligodendroglia Glycoprotein Peptide 35-55 in Experimental Autoimmune Encephalomyelitis in Lewis Rats. Biochem. Biophys. Res. Commun. 2014;443:1118–1123. doi: 10.1016/j.bbrc.2013.12.122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2013.12.122</ArticleId><ArticleId IdType="pubmed">24388990</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira J.P., Sequeira J., Brito M.J. Postinfectious Anti–Myelin Oligodendrocyte Glycoprotein Antibody Positive Optic Neuritis and Myelitis. J. Child Neurol. 2017;32:996–999. doi: 10.1177/0883073817724927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0883073817724927</ArticleId><ArticleId IdType="pubmed">28820014</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie L., Honarmand S., Yagi S., Ruiz S., Glaser C. Anti-Galactocerebroside Testing in Mycoplasma Pneumoniae-Associated Encephalitis. J. Neuroimmunol. 2007;189:129–131. doi: 10.1016/j.jneuroim.2007.06.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneuroim.2007.06.017</ArticleId><ArticleId IdType="pubmed">17651816</ArticleId></ArticleIdList></Reference><Reference><Citation>Briani C., Ferrari S., Campagnolo M., Tagliapietra M., Castellani F., Salvalaggio A., Mariotto S., Visentin A., Cavallaro T. Mechanisms of Nerve Damage in Neuropathies Associated with Hematological Diseases: Lesson from Nerve Biopsies. Brain Sci. 2021;11:132. doi: 10.3390/brainsci11020132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11020132</ArticleId><ArticleId IdType="pmc">PMC7909400</ArticleId><ArticleId IdType="pubmed">33498362</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatum A.H. Experimental Paraprotein Neuropathy, Demyelination by Passive Transfer of Human IgM Anti-Myelin-Associated Glycoprotein. Ann. Neurol. 1993;33:502–506. doi: 10.1002/ana.410330514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410330514</ArticleId><ArticleId IdType="pubmed">7684583</ArticleId></ArticleIdList></Reference><Reference><Citation>Steck A., Yuki N., Graus F. Handbook of Clinical Neurology. Volume 115. Elsevier; Amsterdam, The Netherlands: 2013. Antibody Testing in Peripheral Nerve Disorders; pp. 189–212.</Citation><ArticleIdList><ArticleId IdType="pubmed">23931781</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams C., Diadori P., Schoenroth L., Fritzler M. Autoantibodies in Childhood Post-Varicella Acute Cerebellar Ataxia. Can. J. Neurol. Sci. 2000;27:316–320. doi: 10.1017/S0317167100001074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0317167100001074</ArticleId><ArticleId IdType="pubmed">11097523</ArticleId></ArticleIdList></Reference><Reference><Citation>Mostafa G.A., AL-Ayadhi L.Y. Reduced Serum Concentrations of 25-Hydroxy Vitamin D in Children with Autism: Relation to Autoimmunity. J. Neuroinflamm. 2012;9:686. doi: 10.1186/1742-2094-9-201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-9-201</ArticleId><ArticleId IdType="pmc">PMC3476426</ArticleId><ArticleId IdType="pubmed">22898564</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuki N., Yamamoto T., Hirata K. Correlation between Cytomegalovirus Infection and IgM Anti-MAG/SGPG Antibody-Associated Neuropathy. Ann. Neurol. 1998;44:408–410. doi: 10.1002/ana.410440321.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440321</ArticleId><ArticleId IdType="pubmed">9749612</ArticleId></ArticleIdList></Reference><Reference><Citation>Irie S., Kanazawa N., Ogino M., Saito T., Funato T. No Cytomegalovirus DNA in Sera from Patients with Anti-MAG/SGPG Antibody–Associated Neuropathy. Ann. Neurol. 2000;47:274. doi: 10.1002/1531-8249(200002)47:2&lt;274::AID-ANA24&gt;3.0.CO;2-F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(200002)47:2&lt;274::AID-ANA24&gt;3.0.CO;2-F</ArticleId><ArticleId IdType="pubmed">10665505</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunn M.P.T., Muir P., Brown L.J., MacMahon E.M.E., Gregson N.A., Hughes R.A.C. Cytomegalovirus Is Not Associated with IgM Anti–Myelin-Associated Glycoprotein/Sulphate-3-Glucuronyl Paragloboside Antibody–Associated Neuropathy. Ann. Neurol. 1999;46:267–270. doi: 10.1002/1531-8249(199908)46:2&lt;267::AID-ANA20&gt;3.0.CO;2-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1531-8249(199908)46:2&lt;267::AID-ANA20&gt;3.0.CO;2-M</ArticleId><ArticleId IdType="pubmed">10443896</ArticleId></ArticleIdList></Reference><Reference><Citation>Gövert F., Leypoldt F., Junker R., Wandinger K.-P., Deuschl G., Bhatia K.P., Balint B. Antibody-Related Movement Disorders—A Comprehensive Review of Phenotype-Autoantibody Correlations and a Guide to Testing. Neurol. Res. Pract. 2020;2:6. doi: 10.1186/s42466-020-0053-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42466-020-0053-x</ArticleId><ArticleId IdType="pmc">PMC7650144</ArticleId><ArticleId IdType="pubmed">33324912</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunstreich M., Kreth J.H., Oommen P.T., Schaper J., Karenfort M., Aktas O., Tibussek D., Distelmaier F., Borkhardt A., Kuhlen M. Paraneoplastic Limbic Encephalitis with SOX1 and PCA2 Antibodies and Relapsing Neurological Symptoms in an Adolescent with Hodgkin Lymphoma. Eur. J. Paediatr. Neurol. 2017;21:661–665. doi: 10.1016/j.ejpn.2017.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpn.2017.03.005</ArticleId><ArticleId IdType="pubmed">28389060</ArticleId></ArticleIdList></Reference><Reference><Citation>Honnorat J., Saiz A., Giometto B., Vincent A., Brieva L., de Andres C., Maestre J., Fabien N., Vighetto A., Casamitjana R., et al. Cerebellar Ataxia With Anti–Glutamic Acid Decarboxylase Antibodies: Study of 14 Patients. Arch. Neurol. 2001;58:225. doi: 10.1001/archneur.58.2.225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.58.2.225</ArticleId><ArticleId IdType="pubmed">11176960</ArticleId></ArticleIdList></Reference><Reference><Citation>Dade M., Berzero G., Izquierdo C., Giry M., Benazra M., Delattre J.-Y., Psimaras D., Alentorn A. Neurological Syndromes Associated with Anti-GAD Antibodies. Int. J. Mol. Sci. 2020;21:3701. doi: 10.3390/ijms21103701.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21103701</ArticleId><ArticleId IdType="pmc">PMC7279468</ArticleId><ArticleId IdType="pubmed">32456344</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima G., Inaba M., Bruno M.K. PET-Positive Extralimbic Presentation of Anti-Glutamic Acid Decarboxylase Antibody-Associated Encephalitis. Epileptic Dis. 2014;16:358–361. doi: 10.1684/epd.2014.0666.</Citation><ArticleIdList><ArticleId IdType="doi">10.1684/epd.2014.0666</ArticleId><ArticleId IdType="pubmed">25042574</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinck H.-M. Antibodies against Glutamic Acid Decarboxylase: Prevalence in Neurological Diseases. J. Neurol. Neurosurg. Psychiatry. 2001;71:100–103. doi: 10.1136/jnnp.71.1.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.71.1.100</ArticleId><ArticleId IdType="pmc">PMC1737476</ArticleId><ArticleId IdType="pubmed">11413272</ArticleId></ArticleIdList></Reference><Reference><Citation>Douma B., Ben Younes T., Benrhouma H., Miladi Z., Zamali I., Rouissi A., Klaa H., Kraoua I., Ben Ahmed M., Ben Youssef Turki I. Autoimmune Encephalitis in Tunisia: Report of a Pediatric Cohort. J. Immunol. Res. 2021;2021:6666117. doi: 10.1155/2021/6666117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6666117</ArticleId><ArticleId IdType="pmc">PMC8131150</ArticleId><ArticleId IdType="pubmed">34056010</ArticleId></ArticleIdList></Reference><Reference><Citation>Psimaras D., Carpentier A.F., Rossi C. The PNS Euronetwork Cerebrospinal Fluid Study in Paraneoplastic Syndromes. J. Neurol. Neurosurg. Psychiatry. 2010;81:42–45. doi: 10.1136/jnnp.2008.159483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2008.159483</ArticleId><ArticleId IdType="pubmed">19324868</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson K., Rosenblum M.K., Kotanides H., Posner J.B. Paraneoplastic Cerebellar Degeneration. I. A Clinical Analysis of 55 Anti-Yo Antibody-Positive Patients. Neurology. 1992;42:1931–1937. doi: 10.1212/01.wnl.0000407657.51588.5a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000407657.51588.5a</ArticleId><ArticleId IdType="pubmed">1407575</ArticleId></ArticleIdList></Reference><Reference><Citation>Donfrancesco R., Nativio P., Di Benedetto A., Villa M.P., Andriola E., Melegari M.G., Cipriano E., Di Trani M. Anti-Yo Antibodies in Children With ADHD: First Results About Serum Cytokines. J. Atten. Disord. 2020;24:1497–1502. doi: 10.1177/1087054716643387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1087054716643387</ArticleId><ArticleId IdType="pubmed">27095560</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant R., Graus F. Paraneoplastic Movement Disorders: Paraneoplastic Disorder. Mov. Disord. 2009;24:1715–1724. doi: 10.1002/mds.22658.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22658</ArticleId><ArticleId IdType="pubmed">19562765</ArticleId></ArticleIdList></Reference><Reference><Citation>Avramova B.E., Hristova T., Yordanova M., Vlahova I., Muchinova A., Bojinova V., Konstantinov D. Cerebellar Degeneration as a Rare Paraneoplastic Syndrome in a Child With Hodgkin Lymphoma. J. Pediatr. Hematol. Oncol. 2016;38:470–472. doi: 10.1097/MPH.0000000000000486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPH.0000000000000486</ArticleId><ArticleId IdType="pubmed">26599987</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalmau J. Clinical Analysis of Anti-Ma2-Associated Encephalitis. Brain. 2004;127:1831–1844. doi: 10.1093/brain/awh203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh203</ArticleId><ArticleId IdType="pubmed">15215214</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalmau J., Tüzün E., Wu H., Masjuan J., Rossi J.E., Voloschin A., Baehring J.M., Shimazaki H., Koide R., King D., et al. Paraneoplastic Anti-N-Methyl-D-Aspartate Receptor Encephalitis Associated with Ovarian Teratoma. Ann. Neurol. 2007;61:25–36. doi: 10.1002/ana.21050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21050</ArticleId><ArticleId IdType="pmc">PMC2430743</ArticleId><ArticleId IdType="pubmed">17262855</ArticleId></ArticleIdList></Reference><Reference><Citation>Salovin A., Glanzman J., Roslin K., Armangue T., Lynch D.R., Panzer J.A. Anti-NMDA Receptor Encephalitis and Nonencephalitic HSV-1 Infection. Neurol. Neuroimmunol. Neuroinflamm. 2018;5:e458. doi: 10.1212/NXI.0000000000000458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000458</ArticleId><ArticleId IdType="pmc">PMC5886833</ArticleId><ArticleId IdType="pubmed">29629396</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanleenuwat P., Iwanowski P., Kozubski W. Antiganglioside Antibodies in Neurological Diseases. J. Neurol. Sci. 2020;408:116576. doi: 10.1016/j.jns.2019.116576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2019.116576</ArticleId><ArticleId IdType="pubmed">31726381</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes R.A.C., Hadden R.D.M., Gregson N.A., Smith K.J. Pathogenesis of Guillain–Barré Syndrome. J. Neuroimmunol. 1999;100:74–97. doi: 10.1016/S0165-5728(99)00195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(99)00195-2</ArticleId><ArticleId IdType="pubmed">10695718</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S.-H., Mealy M.A., Levy M., Schmidt F., Ruprecht K., Paul F., Ringelstein M., Aktas O., Hartung H.-P., Asgari N., et al. Racial Differences in Neuromyelitis Optica Spectrum Disorder. Neurology. 2018;91:e2089–e2099. doi: 10.1212/WNL.0000000000006574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006574</ArticleId><ArticleId IdType="pmc">PMC6282238</ArticleId><ArticleId IdType="pubmed">30366977</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran C., Du Pasquier R.A., Cavassini M., Guex-Crosier Y., Meuli R., Ciuffreda D., Waeber G. Neuromyelitis Optica Following CMV Primo-Infection. J. Intern. Med. 2007;261:500–503. doi: 10.1111/j.1365-2796.2007.01794.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2007.01794.x</ArticleId><ArticleId IdType="pubmed">17444889</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>